-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

An Innovative Treatment Option for Appropriate Patients With cGVHD

Sponsor: Sanofi
Program: Product Theaters
Monday, December 12, 2022: 12:15 PM-1:15 PM
Hall J - Theater 7 (Ernest N. Morial Convention Center)
Kathy Marshall, RN, MSN, APRN, AOCNS, Sanofi
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Product Theaters